Key to 400-employee Denali's submission is the FDA allowing measurement of a type of GAG, called heparan sulfate, in ...

Protagonist (Nasdaq: PTGX) is one of a handful of Bay Area drug developers ready to ask the Food and Drug Administration to ...

Generation Bio is a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases. The company is developing redosable therapeutics that reprogram T ...

Vence Bonham Jr., the highest ranking official at the National Human Genome Research Institute (NHGRI), has been put on ...

The excitement late last year over U.S. President Donald Trump's election victory and prospects for a subsequent flurry of mergers and acquisition deals have quickly faded, they say ...

Let's not sugarcoat the facts: venture capital funding in UK agrifoodtech dropped significantly in 2024. But new government ...

Researchers have engineered yeast to efficiently convert methanol into D-lactic acid, a key compound for biodegradable ...

CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing ...

“This is a very important milestone for our company,” said Dr. Abdulkader Rahmo, President and Chief Scientific Officer of SMSbiotech, Inc. “Receiving approval ... of the client from the ...

In a significant move announced in late 2024, Sana Biotechnology has pivoted its strategy to focus primarily on its Type 1 Diabetes (T1D) and Autoimmune Disease (AID) programs. This decision led ...